ABSTRACT-The effect of the root of Salvia miltiorrhiza (SM) on angiotensin II (Ang II)-induced hypertrophic responses was examined in cultured neonatal rat cardiac cells (cardiomyocytes and non-cardiomyocytes). The methanol eluate fraction (SM2) of the water extract and the ethyl acetate-insoluble fraction (SM3) and its soluble fraction (SM4) partitioned from the methanol extract were prepared. Treatment with SM4 (5 -80 mg/ml), not SM2 and SM3, for 24 h produced dose-dependent cytotoxicity against cardiac cells relative to the reduction in viability and the morphological injury of cardiomyocytes. SM2 or SM3 in the absence of Ang II affected neither hyperplastic nor hypertrophic growth of both cell types. However, SM3 (40 mg/ml) attenuated the positive chronotropic responsiveness of cardiomyocytes to Ang II (1 nM) stimulation, whereas Ang II-induced increase in non-cardiomyocyte number was decreased only by SM2 (40 m g/ml) treatment. Furthermore, SM3 suppressed Ang II-induced enlargement of cell size by preceding Ang IIinduced induction of immediate early response gene (c-jun) expression in cardiomyocytes, while SM2 decreased Ang II-induced DNA synthesis in non-cardiomyocytes. Moreover, three phenolic compounds and tanshinone IIA that differed quantitatively among three SM fractions were identified by reverse-phase high performance liquid chromatography. Thus, the present findings indicate that the root of SM is an effective inhibitor of Ang II action and has a plural effective constituent, which possess different pharmacological activities on Ang II-induced hypertrophy and hyperplasia in cultured neonatal rat cardiac cells.
Angiotensin II (Ang II), the active octapeptide and circulating hormone of the renin-angiotensin system, plays a major role in the regulation of fluid balance, blood pressure and cardiac function. Its direct cardiac effects include modulation of Na + , H + and Ca 2+ transport, increasing heart rate and mechanical function, stimulation of protein synthesis and enhancing uptake and utilization of glucose (1, 2) . A growing body of evidence also suggests an important role for Ang II in the pathogenesis of cardiac hypertrophy, since Ang II has been experimentally found to cause cardiomyocyte hypertrophy and fibroblast proliferation (3) . It was established that angiotensin-converting enzyme (ACE) inhibition is associated with a significant improvement in cardiac hypertrophy secondary to hypertension (4) or aortic stenosis (5) and favorably affects coronary hemodynamics in experimental animals (6, 7) and in humans (8, 9) . More recently, Ang II receptor blockers offered a potential effect to patients with congestive heart failure leading to an improved prognosis (10, 11) .
The root of Salvia miltiorrhiza BUNGE (SM), known as Danshen in Traditional Chinese Medicine (TCM), is an important herbal medicine, and it is used in TCM for the treatment of blood-related disorders in women such as amenorrhea, metrorrhagia, mastitis, post-natal abdominal pain, bodily pains due to poor circulation and so on (12). Recently, it is employed as a therapeutic modality in cardiovascular disease including myocarditis and myocardial infarction and is widely used in China (12, 13). Although Danshen is officially listed in the Chinese Pharmacopeia (14) , the exact mechanism for its therapeutic basis has been poorly understood.
In the present study, using three constituent fractions separated from SM extracts, we have systematically exam-ined the pharmacological activities of SM on Ang II action, and we assessed its ability to protect cardiac tissue against hypertrophic responses induced by Ang II in two types of cultured neonatal rat heart cells (cardiomyocytes and non-cardiomyocytes).
MATERIALS AND METHODS

Materials
The 
Preparation and determination of SM extracts
The flow chart for the process of extraction and separation of the three fractions from SM extracts is shown in Fig. 1 . Dried roots (50 g) of SM were extracted twice with water (500 ml) at room temperature. The water extract was applied to a Diaion HP-20 column chromatograph, eluted with water and then with 80% methanol (MeOH) to give an 80% MeOH eluate fraction (SM2, 2.20 g). The residual part was extracted twice with MeOH (500 ml). The MeOH extract was suspended with water and extracted with ethyl acetate (EtOAc) to give an EtOAc-soluble fraction (SM4, 2.08 g), while the residual water layer was lipophilized to yield an EtOAc-insoluble fraction (SM3, 0.46 g).
Qualitative analysis of each SM fraction was performed using a reverse-phase HPLC system. To analyze phenolic compounds, the column (TSK gel ODS-80Ts 4.6´150 mm) was eluted with MeOH-H 2 O (0.1% tetrahydrofuran: TFA) (6:4), flow rate of 1.0 ml /min, a column temperature of 40°C and UV detection at 290 nm. To analyze tanshinone IIA, the column was eluted with MeOH-H2O (0.1% TFA) gradient system from 60% to 100% for 40 min at room temperature by detection at 267 nm. Quantification of three phenolic compounds and tanshinone IIA were performed on three SM fractions based on the peak area method.
Preparation of cardiomyocyte and non-cardiomyocyte cultures
Primary cultures of cardiomyocytes and non-cardiomyocytes were prepared from ventricles of 1-day-old Wistar rats according to the method of Sadoshima et al. (15) as described previously (16) . In brief, to enrich cardiomyocytes, dissociated cells were preplated onto 35-mm culture dishes and incubated for 1 h, which permitted preferential attachment of non-cardiomyocytes to the bottom of the dish. Cardiomyocyte-enriched suspensions were removed from the culture dishes and plated at a density of 2 -5´10 6 cells/ ml per dish. Bromodeoxyuridine (0.1 mM) was added during the first 2 days to prevent proliferation of non-cardiomyocytes. This procedure yielded cultures with 90 -95% myocytes, as assessed by microscopic observation of cell beating. Both cardiomyocytes and non-cardiomyocytes were maintained in serum-containing culture medium, Dulbecco's modified Eagle's medium /F-12 (1:1 vol /vol; Dainippon Pharmaceutical Co., Osaka) supple- mented with newborn calf serum (5% or 10%; Dainippon Pharmaceutical Co.), 3 mM pyruvic acid, 100 mM ascorbic acid, 5 mg/ml insulin, 5 mg/ml transferrin and 5 ng /ml selenium (Boehringer Mannheim, Germany) for 48 h followed by serum-free medium. All experiments were performed 24 h after transferring the cells to serum-free medium.
Measurement of cell viability
Cell viability was measured by MTT assay according to the method of Mosmann (17) . Cardiomyocytes were plated onto a 96-well microplate (3´10 5 cells /well) and cultured for 48 h; after incubation in serum-free medium for 24 h, MTT solution (5 mg/ml) was added to each well (10 ml per 100 ml medium) for 4 h. The MTT metabolites of dark blue crystals were then dissolved in 100 ml of isopropanol containing 0.04 N HCl. The plates were read using a microplate reader (Model 450 /550; Bio-Rad, New York, NY, USA) with a test wavelength of 570 nm and a reference wavelength of 630 nm.
Assessment of spontaneous beating and cell size
The beating status and morphology of cardiomyocytes were monitored with an inverted phase contrast microscope (IX70; Olympus, Tokyo) and video monitor equipped with color video copy processor (SCT-CP710; Mitsubishi, Tokyo). The cell images were introduced into an intensified charged couple device camera (INT-11A; INTER DEC, Osaka) and videotaped using a video cassette recorder (AG-7300; Panasonic, Tokyo). The shape and location of each cardiomyocyte was recorded on a photograph before initiating the experiment and after SM fractions treatment.
The beating status of individual cells was monitored at 37°C for 1 min, and assessed by the alterations in spontaneous beating rate of observed cells.
Cell size was quantified by measuring cell surface area using image processing software (NIH Image 1.59 /Power Macintosh 7200; National Institutes of Health, Bethesda, MD, USA). The alterations in surface area were estimated for each cell and expressed as the percentage of observed cells by planimetry enlarged photography.
Measurement of DNA synthesis and cell density
As an index of DNA synthesis, [ 3 H]-thymidine incorporation was performed as described previously (15) . Serumstarved cells were exposed to SM extract and incubated for 24 h with Ang II or vehicle. [ 3 H]-thymidine (1 m Ci/ml) was added for 6 h before the harvest. Cells were then washed with phosphate-buffered saline (PBS), and 10% trichloroacetic acid was added at 4°C for 60 min to precipitate protein. The precipitate was washed three times with 95% ethanol, then resuspended in 0.2 N NaOH, and the radioactivity was measured by liquid scintillation spectroscopy. The cells were detached with 0.5 ml trypsin (Difco Laboratories, Detroit, MI, USA)-EDTA solution and dissociated by trituration. Cell density was counted using a hemocytometer.
Isolation and Northern blot analysis of RNA
Total RNA was isolated from cardiac cells using the acid guanidinium thiocyanate-phenol-chloroform extraction method (18) . Northern blot analysis was performed according to the procedure described by Kim et al. (19) . The cDNA probes used were as follows: c-jun, 2 kb EcoR I fragment of rat c-jun cDNA; glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 1.3 kb Pst I-Pst I fragment of rat GAPDH cDNA. The cDNA probes were labeled with [
32 P]-dCTP (specific activity, 3 mCi /mmol; New England Nuclear, Boston, MA, USA) by random primer extension using a Bca BEST Labeling Kit (Takara, Shiga). Autoradiography was performed on Kodak XAR-5 film with an intensifying screen at -80°C. Autoradiograms were quantified using an image analyzer (BAS 1500; Fuji Film, Tokyo). Results were normalized to GAPDH gene expression.
Statistical analyses
Depending upon the design of the experiments, statistical significance was determined by either Student's t-test or analysis of variance (ANOVA) combined with Bonferroni's method to compare individual data points for significance. Each value was expressed as the mean ± S.E.M. Differences with P<0.05 were considered statistically significant.
RESULTS
Evaluation of cytotoxicity of SM on cardiomyocytes
To assess whether SM had cytotoxic effects on cardiac cells, cell viability using MTT assay and morphological injury such as formation of blebs, ballooning of the cell membrane or cellular lysates were measured. Figure 2 shows the typical morphological changes in cardiomyocytes by treatment with 40 mg/ml of the three fractions of SM extract for 24 h. As shown in Fig. 3 , at the dosages of 5 -80 mg/ml, treatment with SM2 and SM3 for 24 h barely influenced the growth of cardiomyocytes, whereas SM4 caused a dose-dependent response in the reduction of cell viability. The cell viability was only reduced by 19.5% when the cells were treated with 80 mg/ml of SM4. These findings are consistent with clear morphological injury being induced by SM4 but not SM2 and SM3.
Effect of SM on Ang II-induced cellular responses in cardiomyocytes and non-cardiomyocytes
The effect of SM on Ang II-induced cellular responses was evaluated primarily by spontaneous beating of cardio-myocytes and hyperplasia of non-cardiomyocytes. As shown in Table 1 , the cardiomyocytes beat at a mean of 123 beats /min in serum-free medium for 24 h. Ang II (1 nM) significantly enhanced the beating rate by 1.5-fold compared with that of controls. These increases were suppressed by treatment with SM3 (40 mg/ml) or SM4 (10 -40 mg/ml) for 30 min, while SM2 did not show such effects. SM4 (40 mg/ml) treated cells ceased the beating immediately. Most cells treated with SM4 (10 -40 mg/ml) showed marked morphological changes and lysed within 4 h. On the other hand, the Ang II-induced increases in non-cardiomyocyte numbers were decreased only by treatment with 40 mg/ml of SM2 over a 24 h period. SM2 or SM3 alone had no effect on unstimulated cardiac cells. (16) . In the present study, we characterized the effect of Ang II on the changes in cardiomyocyte size, which is a direct index of hypertrophy. As shown in Table 2 , Ang II (1 nM) caused a pronounced increase in cardiomyocyte size by 141% of controls over a 24-h period, while SM3 (40 mg/ml) markedly suppressed these changes. Cardiomyocyte size was not significantly altered by treatment with SM3 alone.
Therefore, we next examined whether SM3 interfered with the Ang II-induced hypertrophic response via the cjun gene involved in intracellular processes. Figure 4 shows the typical autoradiograms of Northern blot analysis for the effect of SM3 on Ang II-induced c-jun expression. As shown in Table 2 , Ang II (1 nM) rapidly induced c-jun expression in cardiomyocytes after 0.5 h by 1.4-fold. SM3 significantly blunted the induction of c-jun expression by Ang II stimulation (P<0.05). SM3 did not influence c-jun expression in unstimulated cardiomyocytes.
Effect of SM on Ang II-induced DNA synthesis of noncardiomyocytes
Inhibition of Ang II-induced DNA synthesis by treatment with SM2 was observed in non-cardiomyocytes. As shown in Table 3 , exposure of the cells to SM2 (40 mg/ml) for 24 h significantly decreased Ang II-induced increases in the rates of [ 3 H]-thymidine incorporation from 123% to 93% of the control. SM2 alone did not influence the DNA synthesis of unstimulated non-cardiomyocytes.
Qualitative and quantitative analyses of SM compositions
The compositions of SM extracts were analyzed using the reverse-phase HPLC system and divided into phenolic compounds and diterpene quinone pigments. The relative amounts of three phenolic compounds and tanshinone IIA in the three fractions of SM extracts were determined and are shown in Table 4 . It was estimated that tanshinone IIA accounted for 6.62% of SM4 and was less in SM2 and SM3, while lithospermic acid B had a maximal content of 60% in SM2 among the three fractions separated from SM extracts.
DISCUSSION
In the present study, we have confirmed the hypertrophic role of Ang II in cultured cardiac cells according to previously described methods (16, 20) . Namely, Ang II induced a positive chronotropic response and c-jun expression within 30 min and increased cell size after 24 h in cardiomyocytes. It also promoted hyperplasia in noncardiomyocytes as determined by measuring the cell number and DNA synthesis. The constituents of SM were separated into SM2, SM3 and SM4 fractions, which were used in this experiment. Primarily, we found that SM4 but not SM2 and SM3 exhibited cytotoxicity against cultured cardiac cells relative to the reduction of viability and the alterations in morphology of cardiomyocytes. However, the most important findings of this study were that although SM3 and SM2 showed no effect on unstimulated cardiac cells, both reduced Ang II mediated responsiveness. SM3 attenuated Ang II-induced enlargement of cardiomyocyte size accompanying the alterations of c-jun expression, and decreased the Ang II-enhanced beating rate of cardiomyocytes, but it did not affect hyperplasia of non-cardiomyocytes. In contrast, SM2 inhibited Ang II-induced hyperplasia and DNA synthesis of non-cardiomyocytes.
The pharmacological activities of SM have been reported to include inhibition of platelet aggregation, antithrombus formation, improved cardio-cerebral circulation and anti-lipid peroxidation (21 -23) . The effective constituents of SM were long considered to be some liposoluble substances of diterpene quinones (21, 24) . Among them, tanshinone IIA is most abundant and structurally representative, and it has been shown to scavenge lipid radicals in the lipid peroxidation process of myocardial mitochondrial membranes (23) and inhibits low-density lipoprotein (LDL) oxidation in vitro (25) . Recently, SM has been documented to have anti-tumor potential, since 18 tanshinone analogs isolated from SM were tested for their cytotoxic activities against five types of cultured human tumor cell lines (26) . Yoon et al. reported that the tanshinone IIA-induced cell death in HL60 and K562 cell lines was apoptosis (27) . In the present study, tanshinones were found to be the major constituent of SM4, but it did not exist in SM2 and SM3. It was difficult to evaluate the Analyses of the three fractions from SM extract were performed by the reverse-phase HPLC system. The injection volume was 10 m l; UV absorbance was detected at 290 nm.
pharmacological activities of SM4 on Ang II action in the present cultures, because of its myocardial cytotoxicity. Taken together, these findings indicated that SM4 exhibited myocardial cytotoxicity might be attributed to the rich tanshinone IIA content. The hydrophilic extract of SM contains a mixture of natural phenolic compounds, including lithospermic acid A, lithospermic acid B, rosmarinic acid, protocatechualdehyde, protocatechuic acid, caffeic acid and danshensu (28, 29) . These compounds have been shown to have a protective action against peroxidative damage to biomembranes of liver microsomes, hepatocytes and erythrocytes of rats (29) . Lithospermic acid B has been demonstrated to be an effective antioxidant-based myocardial protector (30) , and it also had a hypotensive effect in anesthetized rats (31) . A water extract of SM has been reported to inhibit collagen secretion in cultured human skin fibroblasts (32). Wasser et al. also reported that the water soluble SM extract reversed carbon tetrachloride-induced rat hepatic fibrosis relative to the reduction of transforming growth factor-b1, procollagens I and the procollagens III gene (33) . Ang II was also known to stimulate the expression of transforming growth factor-b1 and to be associated with collagen synthesis in neonatal rat non-cardiomyocytes (34, 35) . In the present study, SM2 contained some phenolic compounds, which mainly were lithospermic acid A, lithospermic acid B and rosmarinic acid. These compounds were also found in SM3, while the amounts of each phenolic compound differed from SM2.
The mechanism underlying the attenuation of Ang IIinduced actions by SM remains an area of considerable interest. Ang II is known to act as a hypertrophic stimulus to cardiomyocytes and a mitogenic stimulus to non-cardiomyocytes, and both responses described to date are apparently mediated by the Ang II type 1 (AT1) receptor (35) . After binding to the AT1 receptor, Ang II rapidly stimulates phospholipase C through G proteins, leading to generation of inositol 1,4,5-triphosphate and diacylglcerol, which transiently activate protein kinase C and increase intracellular Ca 2+ concentration, respectively (36, 37) . The former leads to the expression of immediate early response genes such as c-fos, c-jun and Egr-1 (35, 36, 38) . Several steps in the Ang II signal transduction pathway are logical sites of SM actions. In the present study, SM3 suppressed Ang II-induced enlargement of cell size by preceding Ang II-induced expression of c-jun gene, suggesting that c-jun is involved in the inhibition of Ang II-mediated hypertrophic response by SM3. However, SM3 did not show any effect on Ang II-induced hyperplasia of noncardiomyocytes, whereas, an AT 1 -receptor antagonist suppressed both cardiomyocyte hypertrophy and noncardiomyocyte hyperplasia induced by Ang II. Therefore, the mechanism of SM3 action may differ from an AT 1 -antagonist's one.
These findings suggested that SM contained a plural effective constituent. Thus, one possibility is that the different effect of SM2 and SM3 on Ang II action among cell types may be attributed to the different quantities of each phenolic compound. Systematic analyses of the biological activities of each phenolic compound are needed.
In conclusion, the present findings indicate that the root of SM is an effective inhibitor on Ang II action and contains plural effective constituents, which have different pharmacological activities on Ang II-induced hypertrophy and hyperplasia in cultured neonatal rat cardiac cells.
